Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Shelley Wood

September 22, 2018

Presentation TCT 2018

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Presenter: George L Adams, Tony Das, Klaus Brechtel

September 21, 2018

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Conference News TCT 2014

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

September 13, 2014

Presentation TCT 2013

IN.PACT SFA II

Presenter: Peter Schneider

October 31, 2013

Presentation TCT 2013

Get Real - DES Technologies are Better Suited Than DCB for SFA Indication!

Presenter: Michael Dake

October 31, 2013

Presentation TCT 2012

Role of DCB in SFA Intervention: Predictions Five Years into the Future

Presenter: Thomas Zeller

October 25, 2012

Presentation TCT 2012

DEBATE-SFA: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty Prior to Nitinol Stenting in Patients with SFA and Popliteal Lesions

Presenter: Francesco Liistro

October 22, 2012

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Jason Kahn

November 30, 2011

Advertisement

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

IN.PACT SFA II

Get Real - DES Technologies are Better Suited Than DCB for SFA Indication!

Role of DCB in SFA Intervention: Predictions Five Years into the Future

DEBATE-SFA: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty Prior to Nitinol Stenting in Patients with SFA and Popliteal Lesions

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content